U.S. Veterinary Medical Devices Market: $6.58B by 2032

Market Outlook

By 2032, the U.S. Veterinary Medical Devices Market is expected to reach approximately USD 6.58 billion, expanding at a compound annual growth rate of 9.78% during the forecast period 2027–2032. The market stood at USD 3.76 billion in 2026, following historical valuations of approximately USD 2.85 billion in 2023, USD 3.12 billion in 2024, and USD 3.42 billion in 2025. Values in this report are expressed in USD billions.

The U.S. veterinary medical devices industry operates at the convergence of specialized companion animal surgery, advanced veterinary diagnostic imaging, perioperative patient monitoring, critical care interventions, livestock herd health management, and equine sports medicine. Demand is anchored by profound demographic and structural shifts in pet ownership, widespread humanization of companion animals, rapid expansion of private pet health insurance, and aggressive capital deployment by corporate veterinary hospital networks. Approximately 86.9 million American households own a pet, representing roughly 66% of all households nationwide. Within this installed base, companion canines and felines account for the overwhelming majority of clinical encounters, requiring specialized veterinary medical devices ranging from sub-millimeter microsurgical instruments to high-field magnetic resonance imaging platforms.

Clinical complexity in veterinary medicine has paralleled human tertiary care. The standard of veterinary care has migrated rapidly away from empirical symptom management toward definitive diagnostic-guided therapeutic interventions. Conditions that previously carried guarded or terminal prognoses—such as complex cranial cruciate ligament ruptures, congenital portosystemic shunts, degenerative mitral valve disease, feline chronic kidney disease, intracranial neoplasms, and complex comminuted fractures—are routinely managed using advanced veterinary-adapted medical technologies. In companion canines alone, cranial cruciate ligament disease generates hundreds of thousands of surgical interventions annually, creating a self-sustaining surgical implant and orthopedic fixation ecosystem. Concurrently, the clinical burden of chronic feline degenerative joint disease, canine oncology, and multi-organ emergency admissions sustains persistent demand for high-end patient monitors, fluid delivery systems, digital radiography suites, electrosurgical units, and dedicated veterinary critical care ventilators.

Capital allocation dynamics within veterinary healthcare facilities have simultaneously transformed. The historic fragmentation of independent, single-doctor general practices is yielding to extensive corporate consolidation led by private equity-backed veterinary hospital groups and corporate consolidators. These consolidated networks centralize capital expenditure budgets, establish rigorous technology standardization protocols across hundreds of multi-specialty referral hospitals, and accelerate the procurement cycle for high-margin capital equipment such as point-of-care ultrasound, multi-slice computed tomography, fluoroscopy, and integrated anesthesia workstations. Simultaneously, corporate operators demand medical devices that shorten anesthesia recovery times, optimize operating room throughput, mitigate perioperative morbidity, and integrate natively into cloud-based veterinary practice information management software.

The historical period of 2023 through 2025 was marked by post-pandemic stabilization in clinical caseloads, rapid integration of point-of-care digital imaging, enterprise-level fleet modernization across corporate networks, and substantial inflationary adjustments in veterinary professional service pricing. From 2027 through 2032, market momentum shifts decisively toward minimally invasive veterinary surgical systems, customized orthopedic implants, cloud-connected multi-parameter telemetry, artificial intelligence-assisted diagnostic imaging hardware, and ambulatory field-ready monitoring devices. Vendors that integrate hardware with proprietary consumable pipelines, automated software diagnostics, specialized educational curricula, and enterprise-level service infrastructure will maintain substantial strategic separation over unbundled hardware manufacturers.

Introduction

According to the U.S. Veterinary Medical Devices Market Report, veterinary medicine represents one of the most commercially resilient and technically advancing segments of the domestic healthcare sector. Veterinary medical devices span a vast continuum of care environments, encompassing primary care wellness facilities, 24-hour emergency and critical care trauma centers, board-certified specialty referral institutions, ambulatory equine practices, and commercial livestock production facilities. A canine or feline patient may initially interact with veterinary hardware via routine digital dental radiography and oscillometric blood pressure screening, advance to point-of-care ultrasonography and electrocautery during soft-tissue surgery, and require advanced hemodynamic monitoring, mechanical ventilation, and continuous intravenous infusion inside a dedicated veterinary intensive care unit.

Surgical and operative equipment forms an essential revenue pillar of the domestic market, driven by high procedural volume across both elective interventions and specialized orthopedic and soft-tissue surgeries. Veterinary surgical teams rely on specialized electrosurgical generators, vessel-sealing instruments, specialized rigid endoscopes, micro-laparoscopes, ophthalmic operating microscopes, and high-speed orthopedic power tools. Because veterinary anatomy exhibits wide morphological variation—ranging from a 2-kilogram Chihuahua to a 70-kilogram Mastiff, or a 500-kilogram Thoroughbred—device manufacturers design multi-tiered platforms with specialized modular handpieces, variable-frequency energy delivery, and tailored implant geometries.

Veterinary diagnostic imaging systems represent another dominant category, characterized by rapid capital turnover and high clinical dependency. In contrast to human healthcare, where diagnostic imaging often requires off-site referral, veterinary hospitals emphasize on-site imaging assets to establish rapid diagnoses during the initial patient visit. Digital direct radiography systems, mobile C-arm fluoroscopy suites, high-resolution color Doppler ultrasound, and dedicated low- and high-field magnetic resonance imaging platforms allow veterinary clinicians to evaluate complex pathologies without delaying definitive treatment. Diagnostic imaging hardware serves as the primary gateway for surgical planning, interventional oncology, cardiac staging, and emergency triage.

The economic architecture of the veterinary device market differs fundamentally from human medical device procurement due to the predominance of a cash-based, direct-out-of-pocket payment system. In the United States, third-party commercial pet health insurance penetration hovers around 3.5% to 4.5% of total insured pets, with penetration climbing past 15% in high-income metropolitan areas and specialty hospital caseloads. Because the market is largely unencumbered by bureaucratic Medicare and commercial insurance billing fee schedules, clinical technology adoption is governed by owner willingness-to-pay, perceived clinical outcome value, and practice-level return on capital investment. Veterinary practice owners evaluate capital purchases directly on their ability to generate immediate procedural revenue, reduce technician labor hours, and elevate the clinical standard of care.

Regulatory oversight of veterinary medical devices in the United States is primarily administered by the Food and Drug Administration Center for Veterinary Medicine. Unlike human medical devices governed by stringent 510(k) premarket notifications, De Novo pathways, or Premarket Approvals, veterinary medical devices generally do not require mandatory premarket clearance or efficacy trials prior to commercial distribution. Devices are regulated primarily under post-market adulteration and misbranding provisions, radiation control health and safety standards for imaging equipment, and state-level veterinary medical board regulations. This streamlined premarket framework shortens device commercialization timelines, reduces upfront clinical trial expenditures, and accelerates the iteration cycle between human medical technology innovations and their veterinary-specific adaptation.

From 2027 through 2032, commercial leadership will belong to manufacturers that deliver integrated, end-to-end clinical workflow solutions. Standalone hardware units that lack network integration, dedicated consumables, or specialized technical support face rapid commoditization. The market rewards strategic medtech vendors providing unified hardware-software ecosystems—linking operating room anesthesia machines, multi-parameter monitors, and diagnostic imaging units directly into central practice data repositories to eliminate manual charting, reduce medical errors, and capture every billable procedural unit.

Key Market Drivers: What’s Fueling the U.S. Veterinary Medical Devices Market Boom?

The primary engine of market expansion is the intense emotional humanization of companion animals combined with rising household pet healthcare expenditures. In the United States, pets are overwhelmingly viewed as integral family members, leading owners to pursue advanced diagnostic and therapeutic interventions that mirror human tertiary medicine. This behavioral shift translates into substantial willingness to authorize complex surgeries, such as total hip replacements, interventional cardiac catheterization, surgical oncology resections, and neurosurgical spinal decompression. The commercial availability of specialized veterinary devices that improve post-operative survival and minimize pain is directly matched by owner demand for human-grade clinical care.

A second critical driver is the rapid expansion of the U.S. pet health insurance sector. Insured pets in the United States exceeded 5.7 million by the end of 2024 and maintained strong double-digit annual policy growth through 2026. The growing penetration of high-coverage insurance plans—frequently reimbursing 70% to 90% of eligible emergency, surgical, and diagnostic expenses after deductibles—significantly diminishes out-of-pocket financial friction for pet owners facing high-cost clinical situations. Insured patients are dramatically more likely to be referred to specialty veterinary hospitals, where they undergo advanced procedures involving intraoperative fluoroscopy, rigid laparoscopy, advanced patient monitoring, and specialized bioabsorbable surgical implants.

A third driver is the large-scale corporate consolidation of veterinary practices across North America. Private equity firms and massive veterinary consolidators have acquired thousands of independent veterinary clinics, consolidating them into cohesive healthcare delivery networks. Corporate entities enforce institutional capital allocation processes, replacing fragmented, aging hardware fleets with standardized, enterprise-wide device suites. Consolidators actively invest in modernizing clinical capabilities to maximize gross revenue per clinical encounter, driving high-volume corporate procurement of digital dental radiography systems, high-end ultrasound platforms, specialized electrosurgery systems, and uniform telemetry units across multi-site networks.

A fourth driver is the expanding geriatric companion animal demographic. Advances in veterinary preventive medicine, balanced nutrition, and early disease screening have prolonged the lifespan of domestic canines and felines. The American Veterinary Medical Association highlights that over 40% of the U.S. companion canine population is aged seven years or older. Geriatric pets experience a high incidence of degenerative diseases, osteoarthritis, renal insufficiency, periodontal disease, cardiovascular dysfunction, and neoplastic disorders. Managing these long-term morbidities requires recurring utilization of specialized dental scaling and extraction equipment, fluid warming systems, continuous infusion pumps, physical rehabilitation hardware, and non-invasive blood pressure monitors.

A fifth driver is the rapid clinical adoption of minimally invasive surgery and interventional techniques. Veterinary surgeons and pet owners increasingly favor laparoscopic, thoracoscopic, and arthroscopic procedures over open abdominal or thoracic surgeries due to markedly reduced tissue trauma, decreased post-operative pain, shorter hospitalization stays, and lower infection rates. The widespread execution of laparoscopic prophylactic gastropexy, minimally invasive ovariectomy, arthroscopic fragment removal in elbow dysplasia, and endoscopically guided foreign body retrieval has elevated veterinary rigid endoscopy and micro-instrumentation from niche luxury capabilities to standard operational requirements in modern veterinary hospitals.

A sixth driver is the acute shortage of credentialed veterinary technicians and associate veterinarians, driving strong demand for workflow-optimizing, automated medical devices. Labor supply constraints in U.S. veterinary hospitals have pushed clinical managers to procure automated syringe and infusion pumps with preset drug libraries, multi-parameter monitors featuring intuitive touchscreen interfaces and automated arrhythmia detection, and digital radiography systems that rapidly execute automated exposure titration and image stitching. Equipment that streamlines technical tasks, minimizes manual transcription, and automates documentation relieves severe staff burnout and maximizes daily clinical case volume.

Finally, the livestock, production animal, and commercial equine sectors provide durable, non-cyclical demand for specialized veterinary instrumentation. The U.S. beef cattle, dairy cattle, and swine industries rely heavily on portable point-of-care reproductive ultrasound, automated herd vaccination guns, digital hoof-trimming tables, and specialized herd health diagnostics to maximize agricultural productivity, ensure biosecurity, and maintain animal welfare standards. In parallel, the high-value U.S. equine sports performance sector supports sustained, high-capital expenditure on mobile wireless digital radiography, high-resolution tendon ultrasound, standing CT units, and specialized shockwave therapy devices designed for large-animal musculoskeletal applications.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation across the domestic veterinary medical devices landscape centers on designing equipment optimized specifically for animal physiology, variable anatomy, and high-throughput veterinary operating environments. Rather than repurposing discontinued human medical devices, engineering teams are developing native veterinary platforms that incorporate animal-specific diagnostic algorithms, durable fluid-resistant enclosures, intuitive user interfaces, and unified wireless connectivity.

Patient monitoring represents one of the most technologically transformed categories. Modern veterinary multi-parameter monitors feature tailored physiological software algorithms engineered to accommodate extreme heart rate ranges—from an athletic 25-beats-per-minute equine patient to a critically ill 260-beats-per-minute feline patient in ventricular tachycardia. Innovations in motion-tolerant veterinary pulse oximetry sensors, designed to read accurately through pigmented tissues, non-pigmented tongues, or dense paw pads, have substantially mitigated perioperative monitoring errors. Furthermore, wireless Bluetooth and Wi-Fi telemetry units allow hospitalized patients to move unrestrained in recovery suites while continuously streaming electrocardiographic, respiratory, and temperature data to central nursing dashboards.

Veterinary diagnostic imaging has achieved unprecedented technical sophistication. High-resolution point-of-care ultrasound platforms now integrate veterinary-specific artificial intelligence models that assist clinicians in real-time structural identification, such as executing automated cardiac wall measurements, identifying abdominal fluid accumulations via Point-of-Care Ultrasound protocols, and estimating bladder volumes. In digital radiography, advanced cesium iodide flat-panel detectors provide ultra-low-dose exposures with ultra-fast acquisition times, reducing the necessity for chemical restraint or manual positioning. In advanced cross-sectional imaging, standing equine CT and low-field MRI scanners enable non-invasive musculoskeletal and neurological evaluations without requiring general anesthesia, substantially lowering large-animal procedural mortality risks.

Veterinary orthopedic technology is undergoing a revolution driven by patient-specific engineering and biological fixation principles. The widespread clinical adoption of advanced locking compression plate systems, pre-contoured tibial plateau leveling osteotomy plates, and variable-angle stable fixation implants has elevated successful healing rates in canine orthopedic trauma. Additive manufacturing and three-dimensional printing technologies have enabled specialized manufacturers to produce custom titanium implants, osteotomy cutting guides, and limb-sparing oncologic endoprostheses tailored to the precise micro-CT geometry of an individual animal’s skeleton, transforming the management of complex angular limb deformities and comminuted fractures.

In veterinary surgical instrumentation, energy-based vessel sealing and electrosurgery platforms have redefined soft-tissue operative workflows. High-frequency bipolar energy systems equipped with tissue-impedance feedback deliver rapid, permanent vessel occlusion up to 7 millimeters in diameter with minimal lateral thermal spread. These devices dramatically curtail intraoperative blood loss, shorten general anesthesia duration, and eliminate the need for foreign suture materials in routine procedures such as splenectomy, liver lobectomy, and laparoscopic ovariectomy. Concurrently, specialized micro-debriders, veterinary-specific morcellators, and dedicated surgical suction platforms have expanded the feasibility of complex interventional endoscopy and thoracic interventions.

Infusion and critical care hardware are adopting advanced safety features and human-grade micro-infusion control. Advanced veterinary smart pumps incorporate pre-programmed drug concentration libraries, automated occlusion sensing, and micro-flow rates capable of delivering precise 0.1-milliliter-per-hour infusions essential for critical neonatal kittens or miniature breeds prone to fluid overload. Integrated fluid warming units and convective patient warming systems prevent perioperative hypothermia—a major contributor to delayed anesthetic recovery, coagulopathy, and surgical wound infections in small animal patients.

Digital connectivity and software integration constitute the definitive competitive battleground for device manufacturers. Cutting-edge hardware is no longer marketed as an isolated asset; it is deployed as an interconnected data node. Digital dental sensors, multiparameter monitors, fluid pumps, and blood gas analyzers automatically transmit structured physiological and procedural data directly into electronic medical records via DICOM and HL7 protocols. This seamless data exchange eliminates billing leakage, enhances legal record-keeping, and supports retrospective clinical analytics across large corporate veterinary networks.

Segmentation Insights

The U.S. Veterinary Medical Devices Market is segmented on the basis of product category, animal type, clinical application, end user, technology and modality type, and geography.

By Product Category

Diagnostic Imaging Systems
Diagnostic imaging systems form the largest and most commercially lucrative capital equipment segment within the domestic market, valued at USD 1.28 billion in 2026 and projected to expand to USD 2.29 billion by 2032. This category demonstrated strong historical performance, registering USD 0.94 billion in 2023, USD 1.04 billion in 2024, and USD 1.15 billion in 2025. The category comprises direct digital radiography suites, mobile veterinary C-arms, point-of-care and console-based color Doppler ultrasound machines, computed tomography scanners, and specialized magnetic resonance imaging units.

Direct digital radiography systems represent the volumetric backbone of the diagnostic imaging category, installed in over 85% of modern companion animal practices. Direct-conversion flat-panel detectors equipped with cesium iodide scintillator technology allow instantaneous image rendering, superior spatial resolution, and minimal radiation exposure. The diagnostic imaging segment is propelled by widespread clinical utilization in orthopedic evaluation, pulmonary disease staging, thoracic trauma triage, and dental health evaluations. Point-of-care ultrasound represents the fastest-growing sub-segment, transitioning from specialty referral centers into primary care practices for rapid abdominal fluid detection, cardiac emergency screening, and ultrasound-guided needle biopsies.

Surgical Instruments and Operative Equipment
Surgical instruments and operative equipment represent the second-largest product segment, generating USD 0.89 billion in 2026 and positioned to reach USD 1.58 billion by 2032, after recording USD 0.69 billion in 2023, USD 0.75 billion in 2024, and USD 0.82 billion in 2025. This segment includes general soft-tissue surgical instrumentation, advanced electrosurgical generators, ultrasonic dissectors, vessel-sealing units, rigid laparoscopes and arthroscopes, flexible operating endoscopes, and ophthalmic operating suites.

The expansion of this category is driven by the sheer procedural volume of veterinary surgery, spanning elective spay and neuter operations, gastrointestinal foreign body removals, mass excisions, splenectomies, and thoracic procedures. The ongoing transition from manual suture ligation to advanced bipolar energy-based vessel sealing has dramatically accelerated procedural turnaround times and driven high-margin recurring handpiece revenues. Additionally, the clinical shift toward minimally invasive veterinary laparoscopy and arthroscopy mandates ongoing capital investment in high-definition camera consoles, LED light sources, carbon dioxide insufflators, and specialized micro-instruments.

Patient Monitoring and Anesthesia Systems
Patient monitoring and anesthesia systems reached USD 0.62 billion in 2026 and are forecasted to attain USD 1.10 billion by 2032, building upon historical values of USD 0.47 billion in 2023, USD 0.52 billion in 2024, and USD 0.57 billion in 2025. This product group includes precision vaporizers, veterinary anesthesia delivery machines, dedicated mechanical ventilators, multiparameter patient monitors, capnography monitors, pulse oximetry units, and wireless telemetry networks.

Anesthetic safety represents a paramount clinical priority in veterinary medicine due to heightened species-specific risks of perioperative morbidity and mortality. Multiparameter monitors capable of tracking electrocardiography, non-invasive and invasive arterial blood pressure, end-tidal carbon dioxide, fractional inspired oxygen, core body temperature, and pulse oximetry are mandatory standards across general and specialty facilities. Market growth is heavily driven by practice investments in automated capnography and precision micro-flow anesthesia machines designed to safely manage exotic animals, neonates, and compromised critical patients.

Veterinary Orthopedic Implants and Prosthetics
Veterinary orthopedic implants and prosthetics accounted for USD 0.43 billion in 2026 and are projected to reach USD 0.77 billion by 2032, following historical revenues of USD 0.31 billion in 2023, USD 0.35 billion in 2024, and USD 0.39 billion in 2025. This highly specialized, high-margin category includes titanium locking and non-locking compression plates, cortical and cancellous bone screws, intramedullary pins, external skeletal fixators, specialized tibial plateau leveling osteotomy and tibial tuberosity advancement implants, and total joint replacement prostheses for hips, knees, and elbows.

High clinical prevalence of canine orthopedic trauma and developmental musculoskeletal disorders fuels sustained demand in this segment. Cranial cruciate ligament rupture represents the most common orthopedic surgical pathology encountered in canine medicine, driving massive recurring unit consumption of pre-contoured locking plates and specialized bi-cortical screws. Simultaneously, the rapid expansion of canine total hip replacement systems—incorporating biological ingrowth porous coatings, cemented and cementless femoral stems, and ultra-high-molecular-weight polyethylene acetabular cups—creates substantial revenue generation across board-certified surgical specialty hospitals.

Critical Care and Infusion Devices
Critical care and infusion devices generated USD 0.31 billion in 2026 and are anticipated to grow to USD 0.52 billion by 2032, after posting USD 0.24 billion in 2023, USD 0.26 billion in 2024, and USD 0.28 billion in 2025. This segment comprises veterinary volumetric infusion pumps, micro-syringe drivers, convective patient warming systems, fluid warmers, oxygen therapy cages, nebulizers, and specialized resuscitation equipment.

Modern veterinary intensive care units require continuous intravenous fluid management and precise drug administration. Smart infusion pumps equipped with veterinary-specific dose error reduction systems and comprehensive drug libraries are widely deployed to prevent accidental medication overdosing in low-weight companion animals. Demand is reinforced by the expansion of 24-hour emergency trauma centers, where advanced fluid warming systems and temperature-controlled hyperbaric or oxygen therapy chambers are essential to stabilize septic, hypothermic, or shock-afflicted patients.

Consumables and Wound Care Products
Consumables and wound care products represented USD 0.23 billion in 2026 and are projected to reach USD 0.32 billion by 2032, having demonstrated steady historical growth from USD 0.20 billion in 2023, USD 0.20 billion in 2024, and USD 0.21 billion in 2025. This category encompasses veterinary absorbable and non-absorbable surgical sutures, mechanical skin staplers, advanced hydrogel and antimicrobial foam dressings, cohesive flexible bandages, passive and active drainage catheters, and disposable biopsy punches.

Surgical consumables and specialized wound management products represent the highest-frequency repeat purchasing category in veterinary healthcare. Traumatic soft-tissue wounds, bite lacerations, oncologic resections, and burns require protracted wound healing protocols. The rapid clinical adoption of advanced moist wound healing technologies, antimicrobial silver-impregnated barrier dressings, and negative pressure wound therapy systems has elevated procedural efficacy and expanded the total dollar value per treated patient across both companion animal and equine wound care settings.

By Animal Type

Companion Animals
Companion animals constitute the dominant animal type segment, accounting for USD 2.97 billion in 2026 and forecasted to reach USD 5.26 billion by 2032, reflecting historical valuations of USD 2.22 billion in 2023, USD 2.44 billion in 2024, and USD 2.69 billion in 2025. This segment is driven by domestic canines, domestic felines, equines managed as personal companion animals, and small exotic companion mammals such as rabbits, ferrets, and guinea pigs.

Companion canines and felines drive over 85% of total companion animal device expenditures, supported by high pet ownership density and strong pet humanization dynamics. Canine patients consume substantial volumes of orthopedic implants, advanced diagnostic imaging, and soft-tissue surgical instrumentation. Concurrently, the domestic feline population represents an expanding device market characterized by specialized micro-laparoscopy tools, feline-specific sub-millimeter dental radiography sensors, precision micro-infusion pumps, and specialized blood pressure monitors designed to detect feline systemic hypertension and chronic kidney disease complications.

Production and Food-Producing Animals
Production and food-producing animals accounted for USD 0.79 billion in 2026 and are projected to grow to USD 1.32 billion by 2032, after recording USD 0.63 billion in 2023, USD 0.68 billion in 2024, and USD 0.73 billion in 2025. This segment covers beef cattle, commercial dairy herds, swine, sheep, goats, and commercial poultry production systems.

Procurement behavior in the production animal sector is strictly anchored in agricultural economics, herd productivity, biosecurity protocols, and regulatory food safety standards. Veterinary medical devices in this space are heavily focused on portable, highly durable capital equipment, such as water-resistant, battery-operated point-of-care reproductive ultrasound units used for early bovine pregnancy diagnosis and fetal sexing. Additional device utilization includes specialized bovine hoof-trimming hydraulic chutes, automated high-volume multi-dose vaccination syringes, herd-level mastitis detection hardware, and laparoscopic artificial insemination instrumentation for elite breeding livestock.

By Clinical Application

General Surgery and Soft Tissue Procedures
General surgery and soft tissue procedures represent the largest clinical application segment, valued at USD 1.35 billion in 2026 and projected to expand to USD 2.34 billion by 2032, having tracked from USD 1.03 billion in 2023, USD 1.12 billion in 2024, and USD 1.23 billion in 2025. This category encompasses elective spay and neuter procedures, exploratory laparotomies, gastrointestinal foreign body removals, cystotomies, splenectomies, diaphragmatic hernia repairs, and complex mass excisions.

Soft-tissue surgery represents the operational core of primary care practices and specialty surgical hospitals alike. High case frequency sustains robust capital replacement cycles for surgical lighting suites, hydraulic operating tables, suction units, and electrosurgical generators. The rapid uptake of minimally invasive surgical modalities for routine prophylactic procedures, such as laparoscopic ovariectomy and laparoscopic gastropexy, has created strong demand for high-definition visual towers, insufflators, and specialized laparoscopic clip appliers and vessel sealers.

Orthopedics and Traumatology
Orthopedics and traumatology accounted for USD 0.94 billion in 2026 and are forecasted to attain USD 1.68 billion by 2032, expanding from historical figures of USD 0.70 billion in 2023, USD 0.77 billion in 2024, and USD 0.85 billion in 2025. This segment includes the surgical stabilization of appendicular fractures, correction of angular limb deformities, management of joint dysplasias, execution of stifle stabilization procedures, and total joint arthroplasty.

Canine orthopedic pathology represents one of the highest-revenue clinical specialties in domestic veterinary medicine. The surgical correction of cranial cruciate ligament instability via tibial plateau leveling osteotomy generates hundreds of thousands of procedures annually, requiring specialized air or battery-powered oscillating saws, radial saw blades, pre-contoured locking plates, and precise positioning jigs. The growing availability of advanced total hip, knee, and hock replacement systems in veterinary specialty hospitals further accelerates high-value implant procurement and precision orthopedic tool consumption.

Cardiology and Critical Care Monitoring
Cardiology and critical care monitoring generated USD 0.56 billion in 2026 and is anticipated to reach USD 1.01 billion by 2032, after recording USD 0.42 billion in 2023, USD 0.46 billion in 2024, and USD 0.51 billion in 2025. This application area includes hemodynamic monitoring, non-invasive blood pressure tracking, electrocardiography, echocardiography, defibrillation, telemetry, and critical care mechanical ventilation.

Degenerative mitral valve disease in canines and hypertrophic cardiomyopathy in felines represent widespread chronic cardiac conditions requiring continuous monitoring and serial echocardiographic assessment. In emergency trauma and intensive care facilities, the continuous tracking of central venous pressure, direct arterial lines, pulse oximetry, and end-tidal capnography is mandatory for managing septic shock, acute respiratory distress, severe head trauma, and post-cardiac arrest resuscitation.

Dental and Oral Surgery
Dental and oral surgery accounted for USD 0.45 billion in 2026 and is projected to expand to USD 0.78 billion by 2032, building upon historical values of USD 0.35 billion in 2023, USD 0.38 billion in 2024, and USD 0.41 billion in 2025. This segment covers digital intraoral dental radiography sensors, ultrasonic and piezoelectric dental scalers, high-speed veterinary dental delivery delivery carts, surgical extraction instrumentation, and endodontic equipment.

Periodontal disease represents the most common clinical diagnosis in companion animal medicine, with the American Veterinary Dental College reporting that over 80% of dogs and 70% of cats exhibit active periodontal disease by three years of age. Veterinary dental cleanings, root canal therapy, and surgical tooth extractions represent major profit centers for general practices. The transition from manual scaling to advanced piezoelectric systems and direct digital dental radiography sensors—enabling mandatory full-mouth radiographs during every dental prophylactic procedure—drives intense device utilization and fleet upgrades.

Oncology and Interventional Procedures
Oncology and interventional procedures reached USD 0.26 billion in 2026 and are projected to grow to USD 0.47 billion by 2032, having tracked from USD 0.19 billion in 2023, USD 0.21 billion in 2024, and USD 0.23 billion in 2025. This category includes interventional radiology fluoroscopy suites, microwave and radiofrequency tumor ablation units, electrochemotherapy devices, stereotactic biopsy systems, and specialized interventional stents and catheters.

Cancer is a leading cause of mortality in geriatric dogs and cats, with approximately 50% of dogs over the age of ten developing neoplastic conditions. Advanced veterinary specialty hospitals increasingly deliver localized oncological interventions, including transarterial chemoembolization, tracheal and urethral stenting, and palliative tumor ablation. These complex interventions mandate the installation of high-resolution mobile C-arms, advanced vascular access devices, and precision radiofrequency energy generators.

Neurology and Diagnostic Imaging
Neurology and diagnostic imaging accounted for USD 0.20 billion in 2026 and is forecasted to reach USD 0.30 billion by 2032, up from historical levels of USD 0.16 billion in 2023, USD 0.18 billion in 2024, and USD 0.19 billion in 2025. This segment covers low- and high-field magnetic resonance imaging platforms, multidetector computed tomography scanners, electroencephalography machines, specialized neurosurgical craniotomy drills, and spinal decompression surgical sets.

The high incidence of intervertebral disc disease, spinal cord trauma, intracranial tumors, and idiopathic epilepsy in companion animals drives sustained utilization of advanced cross-sectional neuroimaging. Surgical interventions, including hemilaminectomies, ventral slot procedures, and spinal stabilization, require specialized pneumatic neurosurgical burrs, micro-curettes, spinal fixation pins, and intraoperative neuromonitoring hardware.

By End User

Companion Animal Veterinary Hospitals and Specialty Clinics
Companion animal veterinary hospitals and specialty clinics represent the largest end-user category, generating USD 1.88 billion in 2026 and anticipated to reach USD 3.32 billion by 2032, building from USD 1.41 billion in 2023, USD 1.55 billion in 2024, and USD 1.70 billion in 2025. This segment includes 24-hour emergency trauma centers, board-certified multi-specialty referral hospitals, and advanced secondary care veterinary facilities.

These institutions execute the highest concentration of complex surgeries, interventional procedures, and intensive care admissions. Specialty facilities maintain multiple operating suites equipped with advanced surgical lighting, laparoscopic towers, high-end multiparameter monitors, ventilators, and dedicated CT and MRI rooms. Their procurement patterns prioritize high-performance, clinical-grade medical hardware, comprehensive service maintenance agreements, and advanced software connectivity to handle massive patient throughput and intensive medical records documentation.

Private Independent Veterinary Practices
Private independent veterinary practices accounted for USD 0.98 billion in 2026 and are projected to reach USD 1.68 billion by 2032, following historical revenues of USD 0.77 billion in 2023, USD 0.83 billion in 2024, and USD 0.90 billion in 2025. This category covers single-location and multi-doctor general wellness and primary care veterinary clinics.

While facing corporate acquisition pressure, independent practices represent thousands of clinical locations nationwide. Procurement behavior in independent clinics is heavily focused on versatile, cost-effective capital assets that deliver immediate procedural returns, including digital direct radiography suites, dental cleaning stations, tabletop anesthesia machines, basic multiparameter monitors, and tabletop point-of-care ultrasound systems. Practice owners act as primary purchasing decision-makers, emphasizing ease of use, equipment durability, and attractive vendor financing structures.

Corporate Veterinary Hospital Chains
Corporate veterinary hospital chains generated USD 0.53 billion in 2026 and are expected to achieve USD 0.98 billion by 2032, expanding rapidly from USD 0.38 billion in 2023, USD 0.43 billion in 2024, and USD 0.48 billion in 2025. This segment includes consolidated, private equity-backed veterinary networks operating hundreds or thousands of hospitals under centralized management architectures.

Corporate consolidators leverage massive buying power to negotiate group purchasing contracts, demanding enterprise-wide hardware standardization, aggressive volume discounting, and comprehensive technical training pipelines. Consolidator networks prioritize equipment fleets that standardize clinical protocols across diverse hospital locations, minimize technician training friction, prevent medical errors through automated safety interlocks, and interface directly with enterprise practice management and billing systems.

Academic Veterinary Medical Centers and Research Institutes
Academic veterinary medical centers and research institutes accounted for USD 0.23 billion in 2026 and are anticipated to reach USD 0.39 billion by 2032, having tracked from USD 0.17 billion in 2023, USD 0.19 billion in 2024, and USD 0.21 billion in 2025. This segment comprises the 33 accredited veterinary colleges across the United States, university-affiliated veterinary teaching hospitals, and private veterinary translational research foundations.

Academic veterinary hospitals serve as the tertiary proving grounds for emerging medical technologies, cutting-edge surgical techniques, and advanced interventional clinical trials. These institutions procure bleeding-edge capital equipment, including 3-Tesla research-grade MRI scanners, 64-slice and 128-slice CT systems, robotic-assisted surgical platforms, stereotactic radiosurgery suites, and experimental orthopedic implants. Purchasing decisions are driven by clinical research mandates, resident specialty training requirements, and high-complexity caseloads.

Ambulatory, Mobile, and Large Animal Field Services
Ambulatory, mobile, and large animal field services generated USD 0.14 billion in 2026 and are projected to reach USD 0.21 billion by 2032, after recording USD 0.12 billion in 2023, USD 0.12 billion in 2024, and USD 0.13 billion in 2025. This segment includes mobile companion animal veterinary vans, ambulatory equine field veterinarians, and production animal herd health consulting units.

Ambulatory veterinarians require ruggedized, battery-powered, and lightweight medical devices capable of withstanding extreme environmental conditions, dirt, moisture, and transport vibrations. Demand is dominated by ultra-portable point-of-care ultrasound machines, handheld wireless digital radiography flat panels, battery-operated dental power tools, portable fluid warmers, and mobile vital signs monitors utilized in field stalls, barns, and pasture environments.

By Technology and Modality Type

Digital and Connected Smart Hardware
Digital and connected smart hardware represents the fastest-growing technology segment, valued at USD 1.39 billion in 2026 and projected to expand to USD 2.57 billion by 2032, up from historical levels of USD 1.01 billion in 2023, USD 1.12 billion in 2024, and USD 1.25 billion in 2025. This category includes cloud-linked multi-parameter patient monitors, digital telemetry pods, smart infusion and syringe pumps with automated dose error reduction software, and wireless diagnostic imaging sensors.

The continuous influx of Internet of Things architecture into veterinary clinical practice drives this technology group. Smart hardware units continuously transmit physiological measurements, fluid infusion statuses, and anesthetic gas concentrations to centralized nursing monitoring stations and electronic medical record databases. Practice managers favor connected hardware because it eliminates manual transcription labor, captures billable consumable usage automatically, and alerts nursing staff instantly to patient deterioration, optimizing staff efficiency amidst technician labor shortages.

Stationary Capital Equipment
Stationary capital equipment accounted for USD 1.20 billion in 2026 and is forecasted to attain USD 2.04 billion by 2032, building upon historical values of USD 0.94 billion in 2023, USD 1.02 billion in 2024, and USD 1.10 billion in 2025. This segment covers floor-mounted or ceiling-suspended digital radiography suites, multi-slice computed tomography installations, permanent magnetic resonance imaging platforms, heavy surgical hydraulic tables, ceiling-mounted surgical lighting, and centralized medical gas and scavenging systems.

Stationary equipment forms the permanent infrastructure of veterinary operating suites, diagnostic wings, and radiology suites. While requiring significant upfront capital outlay and specialized facility shielding or structural reinforcements, stationary assets provide unparalleled clinical power, maximum imaging tube heat capacity, high spatial resolution, and long operational lifespans. Demand is maintained by new hospital construction, large-scale facility expansions, and cyclical multi-year fleet replacement programs across corporate and academic medical centers.

Portable and Point-of-Care Devices
Portable and point-of-care devices generated USD 0.79 billion in 2026 and are anticipated to grow to USD 1.41 billion by 2032, after posting USD 0.58 billion in 2023, USD 0.64 billion in 2024, and USD 0.71 billion in 2025. This segment includes handheld point-of-care ultrasound scanners, battery-operated mobile digital X-ray units, handheld pulse oximeters and capnographs, point-of-care blood gas and electrolyte analyzers, and portable ophthalmic tonometers.

Clinical workflows in fast-paced emergency rooms, ambulatory vehicles, and general examination rooms prioritize diagnostic immediacy. Handheld ultrasound systems connecting wirelessly to commercial tablets or smartphones allow veterinarians to complete immediate point-of-care focused assessments for trauma or triage at the patient’s bedside without transferring unstable animals to specialized radiology rooms. Similarly, portable handheld tonometers and blood pressure units streamline primary care wellness exams, driving pervasive hardware adoption across both stationary clinics and mobile field practices.

Disposable and Single-Use Sterile Medical Supplies
Disposable and single-use sterile medical supplies reached USD 0.38 billion in 2026 and are projected to reach USD 0.56 billion by 2032, having tracked from USD 0.32 billion in 2023, USD 0.34 billion in 2024, and USD 0.36 billion in 2025. This category comprises sterile disposable electrosurgical pencils and grounding pads, single-use trocars, specialized laparoscopic retrieval bags, single-use anesthetic breathing circuits, endotracheal tubes, intravenous catheter sets, and sterile disposable drapes.

Stringent infection control standards in companion animal surgery and critical care drive high-volume purchasing of single-use disposable consumables. Veterinary hospitals increasingly recognize that single-use sterile consumables mitigate the risk of healthcare-associated surgical site infections, eliminate hospital staff reprocessing labor, and guarantee device integrity during delicate soft-tissue and orthopedic procedures. Manufacturers capitalize on this trend by bundling specialized disposable consumables with proprietary capital hardware placements.

Regional Insights: Where the Market is Growing Fastest

The U.S. Veterinary Medical Devices Market is geographically divided into the South, West, Midwest, and Northeast. Regional demand exhibits distinct characteristics shaped by state-level companion animal populations, equine training facility density, livestock agricultural concentrations, veterinary college distribution, private equity consolidation penetration, and regional climate variations that influence seasonal trauma and disease profiles.

The South constitutes the largest overall commercial regional market, supported by rapid human population growth, expansive suburban single-family housing markets with high pet ownership rates, and massive livestock operations. The West is positioned for the most rapid technology-driven expansion, propelled by high disposable household incomes, deep pet health insurance penetration, and concentrated venture-backed veterinary health innovations. The Midwest combines dense production animal agricultural sectors with mature companion animal specialty hospital networks. The Northeast remains a highly dense, high-value academic and specialty market defined by elevated procedure pricing and rigorous clinical standards.

South

The South represents the largest geographic segment in the domestic veterinary medical devices landscape, accounting for approximately 35.8% of total national device revenue, or USD 1.35 billion in 2026, and is projected to reach USD 2.38 billion by 2032, following historical revenues of USD 1.01 billion in 2023, USD 1.11 billion in 2024, and USD 1.22 billion in 2025. The region’s commercial dominance stems from an immense companion animal population, extensive equine breeding and performance centers, sprawling commercial beef cattle operations, and rapid net migration into suburban centers across the Sunbelt.

Texas anchors the Southern veterinary medical devices market as one of the largest single state markets in the country. The state contains over 7.2 million pet-owning households and leads the nation in both commercial beef cattle head count and equine populations. Major metropolitan clusters—such as the Dallas-Fort Worth metroplex, Greater Houston, Austin, and San Antonio—host some of the nation’s largest corporate and specialty veterinary hospitals, including massive emergency referral institutions operating multiple dedicated operating suites, high-field MRI units, and advanced linear accelerators. Texas A&M College of Veterinary Medicine & Biomedical Sciences in College Station drives advanced clinical trial hardware adoption and establishes regional benchmarks for veterinary surgical procedures. High canine heartworm disease prevalence across the humid Gulf Coast reinforces sustained demand for diagnostic ultrasound, thoracic radiography, and interventional vascular access devices.

Florida represents an exceptionally high-value companion animal device market, characterized by elevated household wealth in metropolitan regions, an aging human population with high pet companionship attachment, and concentrated corporate veterinary consolidation. The state supports over 5.6 million companion dogs and cats. Metropolitan areas, including Miami-Fort Lauderdale, Tampa-St. Petersburg, Orlando, and Jacksonville, exhibit some of the highest per-capita expenditures on specialized veterinary surgeries, advanced dental procedures, and emergency critical care in the United States. Furthermore, Ocala and Wellington serve as global epicenters for equine sports medicine, show jumping, and thoroughbred training, generating substantial capital expenditure on high-end portable equine digital radiography, standing equine CT systems, high-frequency musculoskeletal ultrasound, and regenerative shockwave devices.

North Carolina and Georgia provide powerful growth corridors within the Southern region. North Carolina benefits from the heavy presence of the Research Triangle Park medtech ecosystem and the North Carolina State University College of Veterinary Medicine in Raleigh, an internationally recognized institution at the forefront of veterinary interventional radiology, oncology, and 3D-printed titanium orthopedic implants. Charlotte and the Research Triangle exhibit high rates of pet health insurance enrollment, accelerating the utilization of advanced patient monitoring and arthroscopy. Georgia, anchored by the dense Atlanta metropolitan sprawl and the University of Georgia College of Veterinary Medicine in Athens, supports extensive regional networks of 24-hour emergency trauma centers. Tennessee, Virginia, Oklahoma, Louisiana, Alabama, Kentucky, and South Carolina further expand regional device demand across both companion animal referral networks and production livestock sectors, including thoroughbred breeding in central Kentucky and intensive cattle production throughout Oklahoma.

West

The West represents the fastest-growing veterinary medical devices region in the United States, capturing approximately 26.4% of total market revenue, or USD 0.99 billion in 2026, and positioned to expand to USD 1.77 billion by 2032, building from USD 0.74 billion in 2023, USD 0.81 billion in 2024, and USD 0.90 billion in 2025. The region is distinguished by the highest pet health insurance penetration rates in the country, exceptional median household incomes, early adoption of digital veterinary technologies, and culturally entrenched pet humanization trends.

California represents the undisputed economic powerhouse of the Western region and the single largest state veterinary device market in the nation. With more than 9 million pet-owning households, California generates massive demand across all medical device modalities. Affluent urban centers, such as the San Francisco Bay Area, Los Angeles County, Orange County, and San Diego, support dense concentrations of private and corporate multi-specialty referral hospitals. Pet owners in these markets routinely authorize multi-thousand-dollar advanced procedures, including total hip replacements, laparoscopic surgeries, and stereotactic radiosurgery for oncology patients. The University of California, Davis School of Veterinary Medicine and Western University of Health Sciences lead extensive veterinary clinical research, driving early adoption of cutting-edge surgical robotics, fluoroscopy-guided interventional equipment, and advanced hemodynamic monitoring. Furthermore, California’s stringent occupational health and safety regulations accelerate the replacement of legacy X-ray equipment with modern, low-radiation digital radiography systems equipped with advanced protective shielding.

Washington and Oregon represent critical high-growth markets in the Pacific Northwest. Seattle, Bellevue, and Portland feature dense concentrations of highly educated, technology-focused pet owners who aggressively purchase comprehensive pet health insurance and demand advanced clinical care standards. Washington State University College of Veterinary Medicine in Pullman and Oregon State University Carlson College of Veterinary Medicine in Corvallis anchor regional specialty referral networks. Veterinary clinics across the Pacific Northwest are leading adopters of connected smart hardware, cloud-integrated multiparameter monitors, digital telemetry, and advanced minimally invasive surgical systems.

Colorado and Arizona represent prominent companion animal and equine healthcare hubs in the Mountain West. The Denver-Boulder and Phoenix-Scottsdale metropolitan areas have experienced explosive population and economic expansion, resulting in the construction of numerous state-of-the-art veterinary emergency and specialty centers. Colorado State University College of Veterinary Medicine and Biomedical Sciences in Fort Collins is globally renowned for its Flint Animal Cancer Center and veterinary orthopedics programs, maintaining high capital investment in advanced computed tomography, linear accelerators, and custom orthopedic implant systems. Utah, Nevada, Idaho, Montana, Wyoming, New Mexico, Alaska, and Hawaii provide expanding contributions to Western device volume, ranging from companion animal emergency hospitals in Salt Lake City and Las Vegas to ruggedized, portable large-animal diagnostic imaging equipment utilized across equine and cattle operations in Montana and Wyoming.

Midwest

The Midwest represents a mature, highly stable, and clinically diverse market, accounting for approximately 21.8% of the national veterinary medical devices market, or USD 0.82 billion in 2026, and forecasted to reach USD 1.41 billion by 2032, after recording USD 0.63 billion in 2023, USD 0.69 billion in 2024, and USD 0.75 billion in 2025. The region combines extensive companion animal healthcare networks in major industrial metropolitan centers with the nation’s highest concentration of commercial livestock agriculture, dairy herds, and swine production facilities.

Illinois and Ohio represent the primary companion animal device revenue drivers in the Midwest. The Greater Chicago metropolitan area supports an extensive infrastructure of large corporate specialty hospitals, 24-hour critical care trauma centers, and private independent practices. The University of Illinois College of Veterinary Medicine in Urbana-Champaign drives clinical innovation across emergency medicine and surgical oncology. Ohio boasts major veterinary medical hubs centered around Columbus, Cleveland, and Cincinnati, anchored by The Ohio State University College of Veterinary Medicine, one of the largest veterinary academic medical centers in North America. Ohio State’s veterinary medical center manages massive annual clinical caseloads, requiring heavy capital outlays for high-throughput digital imaging suites, specialized orthopedic power tools, and intensive care patient monitoring systems.

Minnesota, Wisconsin, and Michigan contribute substantial companion animal and agricultural device volume. Minnesota is a primary center for domestic medical technology innovation, hosting major human and animal device design firms in the Minneapolis-St. Paul corridor. The University of Minnesota College of Veterinary Medicine supports high-volume clinical and surgical operations. Wisconsin and Minnesota serve as foundational dairy cattle and swine production states, generating steady demand for portable bovine ultrasound systems, automated herd health injection equipment, and mastitis monitoring hardware. Michigan, anchored by Michigan State University College of Veterinary Medicine in East Lansing, features dense networks of advanced companion animal practices across Detroit, Grand Rapids, and Ann Arbor.

Indiana, Iowa, Missouri, Kansas, Nebraska, and the Dakotas represent critical agricultural and veterinary epicenters. Iowa State University College of Veterinary Medicine in Ames and Kansas State University College of Veterinary Medicine in Manhattan are national leaders in food animal production medicine, herd health biosecurity, and agricultural diagnostics. Iowa and North Carolina represent the two largest pork-producing states in the country, driving specialized device requirements for commercial swine breeding, herd ultrasound, and computerized vaccination delivery. Simultaneously, growing urban centers, such as Indianapolis, St. Louis, Kansas City, and Omaha, sustain vibrant companion animal specialty surgical, dental, and emergency care facilities.

Northeast

The Northeast accounts for approximately 16.0% of the national market, representing USD 0.60 billion in 2026 and anticipated to grow to USD 1.02 billion by 2032, following historical revenues of USD 0.47 billion in 2023, USD 0.51 billion in 2024, and USD 0.55 billion in 2025. Although geographically more compact than other regions, the Northeast exhibits the highest veterinary hospital density per square mile, the highest average procedure pricing, and an exceptional concentration of premier academic veterinary institutions.

New York is the preeminent state market in the Northeast, characterized by extreme urban clinical density in New York City, Long Island, and Westchester County, complemented by extensive suburban and rural practices across Upstate New York. New York City features world-renowned specialty centers, such as the Schwarzman Animal Medical Center in Manhattan—one of the largest non-profit veterinary teaching hospitals in the world, managing tens of thousands of complex specialty cases annually. This elite clinical environment demands human-grade medical equipment, including high-field MRI scanners, dedicated cardiac catheterization suites, advanced operating microscopes, and multi-bed intensive care monitoring telemetry. Cornell University College of Veterinary Medicine in Ithaca anchors Upstate New York, driving advanced surgical, orthopedic, and equine sports medicine device utilization.

Pennsylvania and Massachusetts represent major centers of academic excellence and corporate veterinary network density. Pennsylvania hosts the University of Pennsylvania School of Veterinary Medicine (Penn Vet), comprising the Matthew J. Ryan Veterinary Hospital in Philadelphia for companion animals and the New Bolton Center in Kennett Square for large animals. Penn Vet is a historical pioneer in veterinary orthopedics, critical care, and equine sports medicine, maintaining cutting-edge capital equipment installations, including robotic imaging and standing equine computed tomography suites. Massachusetts, anchored by Boston’s renowned biotechnology corridor and the Cummings School of Veterinary Medicine at Tufts University in Grafton, supports a highly affluent pet-owning population with extensive health insurance coverage. Boston-area specialty practices exhibit near-universal utilization of direct digital radiography, advanced electrosurgical systems, and specialized laparoscopic equipment.

New Jersey, Connecticut, Rhode Island, New Hampshire, Maine, and Vermont contribute significant companion animal revenue. New Jersey and Connecticut feature some of the highest median household incomes and pet expenditure rates in the nation, fostering dense networks of corporate-owned specialty emergency centers across northern New Jersey, Stamford, and Hartford. In Northern New England, companion animal veterinary care is supplemented by equine pleasure riding practices and specialized dairy herd management across Vermont and Maine, sustaining demand for portable wireless digital radiography and mobile point-of-care ultrasound devices.

Key Market Players

The U.S. Veterinary Medical Devices competitive landscape is characterized by a mix of specialized animal health corporations, diversified medtech conglomerates adapting human technologies to veterinary medicine, and specialized surgical and imaging innovators.

Highly relevant players operating in the U.S. veterinary medical devices industry include:

IDEXX Laboratories, Inc.
Zoetis Inc.
Midmark Corporation
Heska Corporation (Antech Diagnostics / Mars Science & Diagnostics)
Mindray Animal Medical
Covetrus, Inc.
B. Braun Vet Care GmbH
Jorgensen Laboratories, Inc.
Hallmarq Advanced Veterinary Imaging
Sound Technologies (Sound VCA / Antech)
Avante Animal Health (DRE Veterinary)
Integra LifeSciences
Vimian Group (Movora / Veterinary Orthopedic Implants)
Dechra Pharmaceuticals PLC
Esaote North America

IDEXX Laboratories, Inc. maintains an extensive domestic presence across veterinary diagnostic imaging and software connectivity. Its direct digital radiography systems, coupled with proprietary image-management software and tele-radiology consultation networks, are installed across thousands of private and corporate veterinary practices. IDEXX leverages its massive companion animal laboratory diagnostic installed base to cross-sell integrated imaging hardware that communicates directly with its cloud-based practice management platforms.

Zoetis Inc., the world’s largest standalone animal health corporation, has aggressively expanded its device and diagnostic footprint. Through strategic acquisitions and internal engineering, Zoetis delivers point-of-care diagnostic instrumentation, specialized surgical devices, and connected monitoring hardware that integrate seamlessly with its extensive veterinary pharmaceutical and biological therapeutic portfolios.

Midmark Corporation is an established market leader in clinical clinical design and clinical workflow equipment for companion animal practices. Midmark commands substantial domestic market share in veterinary dental delivery delivery workstations, digital intraoral dental radiography sensors, veterinary-specific anesthesia delivery systems, multiparameter patient monitoring units, and clinical exam room and operating suite cabinetry and tables.

Heska Corporation, operating within Mars Science & Diagnostics, provides high-performance point-of-care laboratory hardware, digital radiography flat-panel detectors, advanced ultrasound equipment, and smart infusion pumps. Heska’s hardware placement models—frequently pairing capital equipment leases with long-term consumable and diagnostic test agreements—provide predictable recurring revenue and extensive corporate network penetration.

Mindray Animal Medical has emerged as a disruptive competitor across multiple device categories, capturing market share with high-performance, cost-effective capital systems. The company offers advanced color Doppler ultrasound systems, veterinary-adapted anesthesia workstations with integrated mechanical ventilators, high-acuity multiparameter monitors, and high-definition surgical endoscopy towers engineered specifically for diverse animal sizes.

Covetrus, Inc. operates as both a leading technology platform provider and a massive commercial distributor of veterinary medical devices, surgical instrumentation, and clinical consumables. Covetrus leverages its expansive veterinary supply chain infrastructure and proprietary practice management software to bundle hardware installations with daily consumable fulfillment across thousands of independent and corporate hospitals.

B. Braun Vet Care GmbH delivers clinical-grade infusion therapy systems, surgical instrumentation, suture materials, and regional anesthesia technologies. Its specialized volumetric infusion pumps and syringe drivers, equipped with veterinary-specific dose error reduction software, are deployed extensively in high-acuity veterinary intensive care units and 24-hour emergency trauma facilities.

Jorgensen Laboratories, Inc. serves as a foundational domestic supplier of specialized veterinary surgical instruments, orthopedic hardware, suture materials, anesthesia accessories, and clinical consumables. With an expansive catalog tailored exclusively to veterinary clinical anatomy, Jorgensen maintains strong distribution across private general practices and university veterinary teaching hospitals.

Hallmarq Advanced Veterinary Imaging specializes in the development and installation of advanced cross-sectional imaging hardware engineered specifically for veterinary patients. The company is globally recognized for its unique standing equine MRI systems, which eliminate the lethal risks of general anesthesia in horses, as well as its dedicated companion animal small-footprint 1.5-Tesla MRI and veterinary CT scanners.

Sound Technologies, an Antech Diagnostics company within Mars Petcare, is a market leader in veterinary digital radiography, mobile fluoroscopy, and diagnostic ultrasound. Sound’s digital radiography systems and specialized tele-radiology networks are widely installed across major corporate hospital networks, including VCA Animal Hospitals and BluePearl Specialty and Emergency Pet Hospitals.

Avante Animal Health, formerly operating as DRE Veterinary, is a prominent supplier, refurbisher, and distributor of complete veterinary surgical suites, anesthesia delivery machines, patient monitors, surgical tables, and electrosurgical generators. Avante caters extensively to independent practices and expanding emergency facilities seeking high-value, comprehensive operating room equipment packages.

Integra LifeSciences supplies advanced surgical instrumentation, tissue ablation systems, and regenerative wound care products to the veterinary specialty sector. Its ultrasonic surgical aspirators and specialized neurological and soft-tissue surgical handpieces are widely deployed in board-certified veterinary neurosurgery and oncologic surgical referral centers.

Vimian Group, through its Movora veterinary orthopedics division, represents a global and domestic powerhouse in veterinary musculoskeletal devices. Consolidating premier orthopedic brands, including Veterinary Orthopedic Implants, BioMedtrix, and KYON, Movora commands the leading market position in canine total hip replacement systems, tibial plateau leveling osteotomy plates, and advanced fracture fixation hardware.

Dechra Pharmaceuticals PLC participates strategically in the veterinary equipment landscape through the distribution of specialized anesthesia support devices, equine lameness diagnostic equipment, and fluid therapy products that complement its dominant position in veterinary endocrinology, anesthesia, and dermatology pharmaceuticals.

Esaote North America maintains a strong position in veterinary-dedicated diagnostic imaging, providing point-of-care and console-based ultrasound systems, as well as dedicated low-field magnetic resonance imaging platforms. Esaote’s veterinary systems feature animal-specific transducers, measurement packages, and intuitive software interfaces utilized across companion animal practices and equine sports medicine facilities.

Recent Developments

The U.S. veterinary medical devices landscape has experienced intense merger and acquisition activity, rapid technological convergence, and shifting regulatory dynamics since 2024.

Corporate consolidation across both device manufacturers and veterinary service providers has permanently altered procurement dynamics. The integration of Heska Corporation into the Mars Science & Diagnostics division solidified one of the largest closed-loop diagnostic and device ecosystems in animal health, connecting point-of-care hardware, digital imaging, reference laboratories, and thousands of Mars-owned veterinary hospitals, including Banfield, VCA, and BluePearl. Concurrently, Vimian Group’s ongoing integration of Movora unified leading orthopedic innovators—BioMedtrix, KYON, and Veterinary Orthopedic Implants—under a single corporate umbrella, creating a commanding global and domestic supplier of advanced veterinary total joint replacements, cruciate stabilization implants, and surgical education programs.

Artificial intelligence integration has transitioned from theoretical software concepts to standard commercial features within diagnostic imaging hardware. During 2025 and 2026, leading imaging manufacturers integrated embedded deep-learning algorithms into digital radiography detectors and point-of-care ultrasound consoles. These systems execute automated real-time quality checks, verify patient positioning, calculate vertebral heart scores, identify pulmonary patterns, and detect subtle fracture lines before transmitting studies to off-site board-certified veterinary radiologists. These automated diagnostic co-pilots alleviate severe clinical backlogs in high-volume emergency facilities and empower general practitioners to interpret diagnostic images with heightened clinical diagnostic accuracy.

The expansion of minimally invasive surgery platforms tailored exclusively for veterinary anatomy has accelerated. Major device manufacturers introduced specialized 3-millimeter and 5-millimeter laparoscopic and arthroscopic instrumentation sets, ultra-flexible operating endoscopes, and integrated 4K ultra-high-definition imaging towers designed specifically for low-volume body cavities in toy-breed dogs, felines, and exotic species. The commercialization of compact, multi-frequency vessel-sealing generators with advanced real-time tissue impedance sensing has largely replaced traditional suture ligation in high-volume spay and neuter clinics and complex specialty soft-tissue surgeries.

Regulatory and radiation safety oversight has tightened across state-level jurisdictions. State veterinary medical boards and radiation health departments have increased regulatory scrutiny over occupational radiation exposure during veterinary imaging. This shift has accelerated the obsolescence of legacy film-screen and computed radiography systems, driving mandatory transitions to modern digital flat-panel detectors that drastically reduce radiation doses, shorten exposure times, and minimize the necessity for manual physical patient restraint by veterinary technicians during radiographic exposures.

The corporate veterinary hospital procurement model has reached full institutional maturity. Private equity-backed consolidators, including Thrive Pet Healthcare, National Veterinary Associates, Southern Veterinary Partners, and Amerivet Veterinary Partners, have established formal Value Analysis Committees mirroring human health system procurement architectures. These corporate committees demand rigorous comparative clinical trials, demonstrated mean-time-between-failure data, enterprise-wide cybersecurity compliance for connected hardware, and standardized national equipment service level agreements, placing unorganized, regional equipment vendors at a severe competitive disadvantage.

Finally, supply chain reshoring and domestic manufacturing investments have emerged as strategic imperatives. Following global supply chain vulnerabilities in specialized electronics, rare-earth magnets, and precision medical-grade titanium during previous years, top-tier veterinary device manufacturers have established redundant domestic fabrication facilities for critical surgical implants, machined orthopedic hardware, and specialized anesthetic vaporizers to guarantee uninterrupted fulfillment to U.S. veterinary hospital networks.

Conclusion

The U.S. Veterinary Medical Devices Market is positioned to expand from USD 3.76 billion in 2026 to approximately USD 6.58 billion by 2032, supported by a 9.78% compound annual growth rate during the forecast period 2027–2032. Historical market development from approximately USD 2.85 billion in 2023 to USD 3.42 billion in 2025 demonstrates the exceptional resilience and structural expansion of the domestic veterinary sector. This momentum reflects the enduring impact of companion animal humanization, rising pet health insurance adoption, the aging demographic of companion animals, and widespread capital expenditure across consolidating corporate veterinary hospital networks.

The market’s commercial trajectory is characterized by a definitive transition in how veterinary medical care is delivered. While primary wellness and preventive interventions remain the volume base of veterinary practice, incremental market value is increasingly captured by advanced specialty disciplines, including interventional cardiology, minimally invasive surgical oncology, complex orthopedic reconstruction, and 24-hour critical care monitoring. Veterinary hospitals are evolving into advanced clinical centers operating medical hardware that directly rivals human tertiary healthcare facilities.

The most attractive and expansive device segments through 2032 will include advanced digital diagnostic imaging platforms, point-of-care color Doppler ultrasound, minimally invasive rigid endoscopy towers, precision vessel-sealing electrosurgical units, pre-contoured locking orthopedic fixation systems, smart connected infusion pumps, and wireless multiparameter patient monitoring telemetry. In production animal agriculture and equine sports performance, durable portable digital radiography, water-resistant field ultrasound, and advanced shockwave therapy devices will maintain stable, high-value demand.

From a regional perspective, the South will retain its position as the largest absolute volume market, underpinned by massive companion animal populations, extensive equine centers, and expanding suburban metropolises across Texas, Florida, North Carolina, and Georgia. The West will continue to lead national market velocity through high disposable household incomes, early adoption of digital health technologies, and the nation’s deepest pet health insurance penetration across California, Washington, Oregon, and Colorado. The Midwest provides a balanced, recession-resilient foundation combining high-volume production livestock medicine with sophisticated tertiary academic teaching hospitals. The Northeast maintains its reputation as a high-margin, dense academic and specialty clinical proving ground with the nation’s highest average surgical and diagnostic procedure fees.

For medical device manufacturers, medtech executives, institutional investors, and strategic corporate consolidators, long-term commercial success will not be achieved merely through the distribution of standalone mechanical or imaging equipment. Sustainable competitive advantage belongs to enterprises that own and optimize the complete clinical workflow. Vendors that provide integrated ecosystems—uniting precision hardware, proprietary consumable pipelines, automated artificial intelligence analytics, native practice management software interoperability, comprehensive veterinary clinical training, and dedicated nationwide field service—will capture commanding market share and generate exceptional enterprise value across the expanding U.S. veterinary medical devices landscape through 2032.